Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Saturday, September 26, 2026

Back to today

From X

@AltayCapital 2 clicks

AltayCap on X

The only industries where obvious capital allocation lingo is useful is leasing / banking / insurance. It's much more nebulous in operating businesses that do real things. $AER ceo saying the cheapest commercial jets are on the NYSE under the ticker AER is easy to understand. As math is pencilling out cost of new orders vs buying back stock. $FOUR competes in the real world. Leasing/banking products are fungible. Much harder biz to forecast. Cap allocation is still important, but a lot harder.
@calvinblissett 1 click

Calvin Blissett on X

Other than the backlog growing linearly every year and taking that at face value here are some secular trends I found that support growth pertinent to $BUKS: Management repeatedly points to several things in earnings calls: developing additional FAA-approved STCs; getting repeat installations from STCs it has already developed; bringing fabrication in-house rather than outsourcing it; increasing production capacity; selling more kits that customers install themselves; doing larger and more complicated special-mission aircraft; expanding systems-integration work; and growing internationally. During FY2026, BUKS invested approximately $2.7M in developing/producing new products BUKS’s Aerospace segment isn’t primarily an OEM. Its core exposure is modifying King Air, Cessna turboprop, Learjet and increasingly Challenger aircraft for ISR, aerial surveillance, sensors, search-and-rescue and other special missions; installing avionics/electronics; and selling modification kits under FAA STCs. 1. The turbine aircraft fleet BUKS targets is projected to grow ~2% annually for 20 years The FAA’s Aerospace Forecast FY2025–2045 projects the turbine general-aviation fleet to grow 2.1% annually through 2045. In contrast, the piston fleet is expected to shrink slightly. The FAA expects essentially all net growth in the traditional GA fleet to come from turbine aircraft. That’s highly relevant because BUKS specifically says its businesses concentrate on King Air and Cessna turboprops, Learjets and other turbine aircraft. 2. Business-jet deliveries are projected to grow ~3% annually for the next decade Honeywell’s 2025 Global Business Aviation Outlook forecasts: 8,500 new business jets worth $283 billion over the next 10 years, the highest value in the forecast’s 34-year history. It projects deliveries to grow at approximately 3% annually, with 2026 deliveries expected to increase another 5% YoY. 3. Honeywell found that 91% of business-aircraft operators expect to fly the same amount or more, with 28% expecting increased flying. The FAA separately forecasts total general-aviation flight hours to increase 19% from 2023 through 2045, with turbine, rotorcraft and experimental aircraft driving the increase. Higher utilization generally supports demand for upgrades and keeping existing aircraft economically useful. That’s relevant to BUKS because many of its products effectively extend or expand the capabilities of existing airframes rather than requiring operators to buy a new aircraft.
@calvinblissett 1 click

Calvin Blissett on X

$BMBL: Warren Buffett in the salad oil scandal days of American Express used scuttlebutt to determine the strength of the most by going to restaurants. Bumble has a similar level of horrible sentiment today. My tiny brain just realized I am in the epicenter of dating apps (being at a 60k student university). I will be asking every girl for the next few weeks their experiences and perspectives on the different dating apps.

Investor Letters

All letters

IEH Corporation: Research Note

IEH booked $3.6 million in mobile-defibrillator connector orders, lifting its medical revenue outlook and diversifying beyond aerospace and…

IEHC $73M
Atrium Research - Equity Research 12 clicks

Research Roundup Vol. LIII

Micron’s customer agreements, Analog Devices’ acquisitions, Ondas’ GATE deal and Baker Hughes’ power systems position them for AI…

ONDS $4.3B
Monte Independent Investment Research 4 clicks
KRYS · short

Krystal Biotech INC

Krystal Biotech is a profitable commercial-stage biotech with an $8.7 billion enterprise value and one FDA-approved topical gene therapy,…

KRYS $10B
Value Investors Club

Forgive me Father, I have Sabled.

Sable Offshore restarted Santa Ynez oil flows under a Defense Production Act order, targeting 50,000 barrels daily and a path to 60,000…

SOC $664M
Triple S Special Situations Investing 3 clicks

AI turned my Report into a Video

Google’s NotebookLM turned a 30-page Douglas Dynamics report into an 8-minute video, while Custom GPTs screen earnings transcripts for…

PLOW $906M
Hidden Gems Investing

Publications we follow

Every publication on this site, hand-picked.

110 publications

Newsletters 93

YouTube 4

Blogs 12

Seeking Alpha 42 of 200

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

72 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.